Istari Oncology, Inc. is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. The Company was founded in 2016 to continue research and clinical development of technology discovered at Duke University.
6 Davis Drive
Research Triangle Park, NC 27709
P.O. Box 2896
Chapel Hill, NC 27515